| 000 | 01357 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513081632.0 | ||
| 264 | 0 | _c19930514 | |
| 008 | 199305s 0 0 eng d | ||
| 022 | _a0001-5792 | ||
| 024 | 7 |
_a10.1159/000204580 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArthur, C K | |
| 245 | 0 | 0 |
_aCombined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. _h[electronic resource] |
| 260 |
_bActa haematologica _c1993 |
||
| 300 |
_a15-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetaphase |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aMa, D D | |
| 773 | 0 |
_tActa haematologica _gvol. 89 Suppl 1 _gp. 15-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000204580 _zAvailable from publisher's website |
| 999 |
_c8474934 _d8474934 |
||